Showing results (1-10 of 113) with videos related to
Sort By:
Pageof 12
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|August 20, 2003
Extracorporal low-density lipoprotein elimination by immunoadsorptionM M Ritter, K G ParhoferBritish Journal of Clinical Pharmacology|December 2, 1998
Effects of acipimox on haemorheology and plasma lipoproteins in patients with mixed hyperlipoproteinaemiaC Otto, K G Parhofer, M M Ritter, et al.Journal of Lipid Research|April 29, 2000
Influence of LDL apheresis on LDL subtypes in patients with coronary heart disease and severe hyperlipoproteinemiaB M Schamberger, H C Geiss, M M Ritter, et al.Lipids|August 12, 1999
Lipoprotein (a) metabolism estimated by nonsteady-state kineticsK G Parhofer, T Demant, M M Ritter, et al.Der Internist|May 13, 2020
[Lipidology update : Evidence-based treatment of dyslipidemia]K G ParhoferIdrugs : the Investigational Drugs Journal|May 10, 2008
Treatment of hypercholesterolemiaK G ParhoferMMW Fortschritte Der Medizin|February 24, 2001
[Homocysteine--CRP--lipoprotein (a). When do you evaluate the "new" risk factors]K G ParhoferExperimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 10, 2005
Beyond LDL-cholesterol: HDL-cholesterol as a target for atherosclerosis preventionK G ParhoferAtherosclerosis. Supplements|January 30, 2013
How will new medications affect the lipoprotein apheresis situation in Germany?K G ParhoferPageof 12